Shin Nippon Biomedical Laboratories, Ltd.

Overview

• HeadquartersM0¹

See how the biggest companies compare on our leaderboards

Corporate structure

Shin Nippon Biomedical Laboratories, Ltd. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Filings

5 filings to the SEC since October 2021: 5 other. The latest 5:

1. Jun 8, 2023SC TO-T/A EDGAR
2. May 26, 2023CORRESP EDGAR
3. May 26, 2023SC TO-T/A EDGAR
4. May 5, 2023SC TO-T EDGAR
5. Apr 17, 2023SC TO-C EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Shin Nippon Biomedical Laboratories, Ltd. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

• Satsuma Pharmaceuticals, Inc.SC 13D/A Apr 17, 2023 to Jun 8, 2023²
• Wave Life SciencesSC 13D/A Aug 12, 2022³